To further help in the fight against COVID-19, our COPE team has developed a novel 6-week teletherapy program aimed to help patients adapt to the negative emotions and behaviors surrounding the COVID-19 pandemic.
There’s a bright future ahead for treating Major Depression in 2020 and beyond thanks to ketamine. IV Ketamine and intranasal esketamine (Spravato) are helping patients find relief. And, with IV Ketamine, some patients experience relief within hours!
The symptoms of depression can be crippling for those who suffer from this illness. Depression can interfere with your daily activities, causing persistent feelings of sadness, loss of interest, and hope.